Effectiveness and risk associated with infliximab alone and in combination with immunosuppressors for Crohn’s disease: a systematic review and meta-analysis

Objective: Infliximab (IFX) monotherapy and IFX combined with immunosuppressors have been used in the treatment of Crohn’s disease. However, the differences between combination therapy and IFX alone remain controversial. The aim of this meta-analysis was to evaluate the effectiveness and risk associ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Clin Exp Med
Hlavní autoři: Wang, Zhe, Wang, Jingshuai, Fu, Liu, Dong, Shuang, Ge, Yanli, Zhang, Junjie, Huang, Binbin, Wang, Qizhi, Wang, Zhirong
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483967/
https://ncbi.nlm.nih.gov/pubmed/26131059
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky